According to a newly released analysis by Future Market Insights, the global drug discovery informatics market was valued at US$ 2.9 billion in 2022 and is projected to expand significantly to US$ 12.5 billion by 2033, registering an impressive CAGR of 14.4% during the forecast period.
The discovery informatics segment is expected to lead the market, with a projected CAGR exceeding 15% from 2023 to 2033. This growth is driven by the increasing adoption of informatics solutions to streamline drug discovery processes, enhance efficiency, and reduce costs in pharmaceutical and biotechnology industries.
Key factors driving the market include advancements in computational tools, artificial intelligence (AI), and big data analytics, which are revolutionizing drug discovery workflows. Additionally, growing investments in R&D and the need for accelerated drug development timelines are fueling demand for informatics platforms.
A Full Report Overview – https://www.futuremarketinsights.com/reports/drug-discovery-informatics-market
Key Takeaways:
- The drug discovery informatics market is expected to grow from US$ 2.9 billion in 2022 to US$ 12.5 billion by 2033, with a CAGR of 14.4%.
- Discovery informatics is the highest revenue-generating segment, anticipated to grow at a CAGR of over 15% during the forecast period.
- Technological advancements in AI and big data analytics are enhancing drug discovery processes and driving market growth.
- Increasing R&D investments and the push for accelerated drug development are key factors boosting market demand.
Market Drivers
- Focus on Precision Medicine: The growing emphasis on precision medicine is driving demand for advanced informatics solutions that enhance drug discovery processes tailored to specific patient groups based on genetic and molecular profiling.
- Technological Advancements: Innovations in data storage, management, processing, and analysis are enabling more efficient drug discovery workflows, making informatics solutions indispensable in pharmaceutical research.
- Increased Data Availability: The expansion of gene sequencing and molecular profiling techniques has significantly increased the volume of data available for analysis, further propelling the need for robust informatics solutions.
- Efficiency in Drug Development: Drug discovery informatics streamlines the process of discovering and developing new medications, reducing both time and costs compared to traditional methods.
Regional Insights
- The United States is expected to dominate the market, projected to account for approximately USD 4.1 billion by 2033.
- Other notable markets include the United Kingdom, anticipated to reach USD 669 million, and Japan, expected to reach USD 731 million by 2033.
Competitive Analysis
Some of the key companies in the drug discovery informatics market include Certara, Boehringer Ingelheim International GmbH, Infosys Ltd., Charles River Laboratories, Collaborative Drug Discovery, Inc., Eurofins DiscoverX Products, Jubilant Biosys, Selvita, Novo Informatics Pvt. Ltd., ChemAxon Ltd., Albany Molecular Research Inc., Oracle, Accenture, Agilent Technologies, Inc., and Illumina, Inc.
Some of the recent developments of key Drug Discovery Informatics providers are as follows:
- In April 2022, Iktos, a provider of Artificial Intelligence for new drug design announced their collaboration with Teijin Pharma Limited to evolve Artificial Intelligence for small molecules drug discovery.
- In January 2022, Shanghai Fosun Pharmaceutical collaborated with Insilico Medicine for the discovery and development of drugs utilizing AI technology.
- In September 2019, Takeda Pharmaceutical Company Limited and Evotec cooperated to build five drug discovery projects with Evotec clinical candidates for further clinical development by Takeda across different treatment areas.
- In August 2019, Certara introduced the 19.6 version of D360, which was the company’s scientific informatics platform for drug discovery and development. This platform enables a scientific researcher to access, exchange, and comprehend data.
- In August 2019, Voronoi, a South Korean drug discovery and development biotech firm, has chosen CDD Vault, a hosted platform for storing chemistry and biology data, to handle the firm’s joint projects and drug discovery data. Similarly, recent developments related to the companies in Drug Discovery Informatics Market have been tracked by the team at Future Market Insights, which are available in the full report.
Market Segments Covered in Drug Discovery Informatics Market Analysis
By Technique:
- Discovery Informatics
- Identification, Validation, & Assay Development Informatics
- Lead Generation
- Enzymes
- Other Cleanings
- Development Informatics
- Lead Optimization
- FHD Preparation
- Phase IA
- Phase IB/2
By Mode:
- Outsourced
- In-house
By Services:
- Sequence Analysis Platforms
- Molecular Modelling
- Docking
- Clinical Trial Data Management
- Other Services
By Region:
- North America
- Latin America
- Europe
- APAC
- Middle East and Africa (MEA)
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
Teledentistry Market
Dental Adhesives Market
High Potency API Contract Manufacturing Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube